Adenomyosis
Conditions
Interventions
Control Group:Fuzheng Qingyu prescription placebo
Experimental Group:Fuzheng Qingyu formula granules
Sponsors
Yueyang Hospital of Integrated Chinese and Western medicine, Shanghai University of Traditional Chinese medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: ? It meets the diagnostic criteria of Western medicine for adenomyopathy and the dialectical standard of Qi deficiency and blood stasis. ? Women =20 years old and =50 years old. ? Understand and agree to participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: ? Patients with severe hepatic and renal insufficiency, blood system disorders, and psychiatric history. ? Pregnant or lactating women. ? Known to be severely allergic to the Chinese medicine ingredients used in this study. ? Those who are taking female progesterone drugs or have stopped taking female progesterone drugs for less than 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate of dysmenorrhea; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analog dysmenorrhea score;Cox Menstrual Symptom Scale;Pictorial Blood loss Assessment Chart;Endometriosis Health Profile-5;Depression score;Anxiety score;Stress score;Sex Hormones;anti-mullerian hormone;carbohydrate antigen 199;carbohydrate antigen 125;ultrasonic elastography;Blood routine test;Liver function;Renal function;TCM Syndrome scoring form; | — |
Countries
China
Contacts
Public ContactYang Cao
Yueyang Hospital of Integrated Chinese and Western medicine, Shanghai University of Traditional Chinese medicine
Outcome results
None listed